Inspire Pharmaceuticals, Inc. Names Dr. Charles Johnson as Executive Vice President of Research and Development and Chief Medical Officer

DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today it has entered into an Executive Employment Agreement with Charles A. Johnson, M.D., who will become Executive Vice President of Research and Development and Chief Medical Officer, effective September 15, 2010.

MORE ON THIS TOPIC